MedPath

Clinical study to determine accuracy of test device in low blood oxygen level.

Completed
Conditions
Other general symptoms and signs,
Registration Number
CTRI/2019/06/019933
Lead Sponsor
AmZetta Technologies Pvt Ltd
Brief Summary

The SpO2 probe is designed for non-invasive spot-check of arterial oxygen saturation (SpO2) and pulse rate for the intended operator (patient/user) in a home, hospital or clinical environment.

The purpose of trial is to determine the accuracy of the test device as per the specified standard.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Subject is willing to give written informed consent for participation in the study.
  • Healthy Male or Female, between 18-45 years of age.
  • Subject willing to undergo controlled desaturation.
  • Subject in a general healthy state with no evidence of ongoing medication and ongoing illness that effect the participation into the study.
  • At least 2 darkly pigmented subjects or 15% of the subject pool, whichever is larger will be recruited into the study.
Exclusion Criteria
  • Subject has any deformity at sensor site location 2.
  • Pregnant women or nursing mothers 3.
  • Subject has known respiratory condition 4.
  • Subject has known cardiovascular disease 5.
  • Subjects with known clotting disorders (self-reported) history of bleeding disorders or personal history of prolonged bleeding from injury, history of blood clots, haemophilia, current use of blood thinner: prescription or daily use of aspirin.
  • Subject on psychotropic drugs 7.
  • Subject with Diabetes 8.
  • Subject with artificial nails or nail polish 9.
  • Subject with Raynaud’s disease 10.
  • Critically ill individuals 11.
  • Smokers 12.
  • Subjects with Haemoglobin <9 g/dL- Self reported 13.
  • Subjects with carboxyhemoglobin levels larger than 3% 15.
  • The subject has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.
  • Self-reported health conditions as identified in the Health Assessment Form (self-reported), diabetes, thyroid disease, kidney disease / chronic renal impairment, history of seizures (except childhood febrile seizures), epilepsy, history of unexplained syncope, recent history of frequent migraine headaches, recent head injury, cancer / chemotherapy.
  • Subject participating in any other clinical trial or have had participated in any clinical trial within last 3 months or is on a follow up for any clinical trial.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The values obtained from the test device will be compared by the test values obtained by the co-oximeter and statistical analysis will be done as per the EVS-EN ISO 80601-2-61:2011.same day
Secondary Outcome Measures
NameTimeMethod
Ease of use of test device will be determined as per the list of questionnaires.same day

Trial Locations

Locations (1)

Sanjivani Super speciality hospital

🇮🇳

Ahmadabad, GUJARAT, India

Sanjivani Super speciality hospital
🇮🇳Ahmadabad, GUJARAT, India
Dr Gaurav H Chhaya
Principal investigator
9825324056
gaurav.chhaya2010@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.